Nikkiso Co., Ltd. is a global enterprise that operates across a diverse range of sectors, including industrial solutions, aerospace components, precision instruments, deep ultraviolet (DUV) LED technology, and medical devices. The company's operations are primarily organized into two main divisions: the Industrial Business segment and the Medical Business segment. The Industrial Business segment focuses on the development, production, sales, and maintenance of specialized industrial pumps, such as leak-proof pumps, accurate metering pumps, and cryogenic pumps vital for liquefied natural gas (LNG) transfer. This division also provides advanced water conditioning systems for thermal and nuclear power plants, along with integrated system products that combine water treatment capabilities with automation and other sophisticated functions. Furthermore, it supplies warm laminating systems, various electronic component manufacturing equipment, carbon fiber reinforced plastic (CFRP) products designed for civilian aircraft, and deep ultraviolet LEDs and their associated technologies. Within the Medical Business segment, Nikkiso is engaged in the manufacturing, distribution, and servicing of products and medical supplies crucial for kidney-related therapies, including hemodialysis, peritoneal dialysis, and continuous renal replacement therapy. Its key offerings encompass comprehensive dialysis systems, dialyzers, blood tubing lines, and powdered dialysate. This segment also produces blood glucose monitoring devices, air purification units, innovative ozone-water hand-washing systems, and microwave-based surgical instruments. Founded in 1950 as Nippon Kikai Keiso Kaisha Ltd., the company officially changed its name to Nikkiso Co., Ltd. in November 1968. Its corporate headquarters are located in Tokyo, Japan.
最新数据
JP¥3,945
+JP¥40.00 · +1.02%
盘中时间采用JST。市场数据可能有所延迟。
Nikkiso Co., Ltd. is a global enterprise that operates across a diverse range of sectors, including industrial solutions, aerospace components, precision instruments, deep ultraviolet (DUV) LED technology, and medical devices. The company's operations are primarily organized into two main divisions: the Industrial Business segment and the Medical Business segment. The Industrial Business segment focuses on the development, production, sales, and maintenance of specialized industrial pumps, such as leak-proof pumps, accurate metering pumps, and cryogenic pumps vital for liquefied natural gas (LNG) transfer. This division also provides advanced water conditioning systems for thermal and nuclear power plants, along with integrated system products that combine water treatment capabilities with automation and other sophisticated functions. Furthermore, it supplies warm laminating systems, various electronic component manufacturing equipment, carbon fiber reinforced plastic (CFRP) products designed for civilian aircraft, and deep ultraviolet LEDs and their associated technologies. Within the Medical Business segment, Nikkiso is engaged in the manufacturing, distribution, and servicing of products and medical supplies crucial for kidney-related therapies, including hemodialysis, peritoneal dialysis, and continuous renal replacement therapy. Its key offerings encompass comprehensive dialysis systems, dialyzers, blood tubing lines, and powdered dialysate. This segment also produces blood glucose monitoring devices, air purification units, innovative ozone-water hand-washing systems, and microwave-based surgical instruments. Founded in 1950 as Nippon Kikai Keiso Kaisha Ltd., the company officially changed its name to Nikkiso Co., Ltd. in November 1968. Its corporate headquarters are located in Tokyo, Japan.
日内区间
当前JP¥3,945
52周区间
当前JP¥3,945
盘中时间采用JST。市场数据可能有所延迟。
Nikkiso Co., Ltd. is a global enterprise that operates across a diverse range of sectors, including industrial solutions, aerospace components, precision instruments, deep ultraviolet (DUV) LED technology, and medical devices. The company's operations are primarily organized into two main divisions: the Industrial Business segment and the Medical Business segment. The Industrial Business segment focuses on the development, production, sales, and maintenance of specialized industrial pumps, such as leak-proof pumps, accurate metering pumps, and cryogenic pumps vital for liquefied natural gas (LNG) transfer. This division also provides advanced water conditioning systems for thermal and nuclear power plants, along with integrated system products that combine water treatment capabilities with automation and other sophisticated functions. Furthermore, it supplies warm laminating systems, various electronic component manufacturing equipment, carbon fiber reinforced plastic (CFRP) products designed for civilian aircraft, and deep ultraviolet LEDs and their associated technologies. Within the Medical Business segment, Nikkiso is engaged in the manufacturing, distribution, and servicing of products and medical supplies crucial for kidney-related therapies, including hemodialysis, peritoneal dialysis, and continuous renal replacement therapy. Its key offerings encompass comprehensive dialysis systems, dialyzers, blood tubing lines, and powdered dialysate. This segment also produces blood glucose monitoring devices, air purification units, innovative ozone-water hand-washing systems, and microwave-based surgical instruments. Founded in 1950 as Nippon Kikai Keiso Kaisha Ltd., the company officially changed its name to Nikkiso Co., Ltd. in November 1968. Its corporate headquarters are located in Tokyo, Japan.
日内区间
当前JP¥3,945
52周区间
当前JP¥3,945
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(JPY) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 2156.42亿 JPY | 2133.79亿 JPY | 1926.29亿 JPY | 1771.09亿 JPY | 1677.59亿 JPY |
| 销货成本 | 1506.29亿 JPY | 1597.57亿 JPY | 1454.37亿 JPY | 1357.5亿 JPY | 1205.99亿 JPY |
| 毛利 | 650.13亿 JPY | 536.22亿 JPY | 471.92亿 JPY | 413.59亿 JPY | 471.6亿 JPY |
| 研究与开发 | 34.35亿 JPY | 37.74亿 JPY | 27.33亿 JPY | 19.18亿 JPY | 24.54亿 JPY |
| 销售、一般及管理费用 | 417.65亿 JPY | 435.22亿 JPY | 398.96亿 JPY | 428.97亿 JPY | 421.93亿 JPY |
| 营业费用 | 501.04亿 JPY | 472.96亿 JPY | 426.29亿 JPY | 448.15亿 JPY | 446.47亿 JPY |
| 利息收入 | 24.92亿 JPY | 1.54亿 JPY | 1.09亿 JPY | 1.06亿 JPY | 5100万 JPY |
| 利息支出 | 11.43亿 JPY | 9.64亿 JPY | 7.42亿 JPY | 12.4亿 JPY | 10.66亿 JPY |
| 折旧和摊销 | 112.46亿 JPY | 112亿 JPY | 104.51亿 JPY | 98.17亿 JPY | 98.61亿 JPY |
| 营业利润 | 149.09亿 JPY | 63.26亿 JPY | 45.63亿 JPY | −34.56亿 JPY | 25.13亿 JPY |
| 净利润 | 136.53亿 JPY | 79.56亿 JPY | 90.72亿 JPY | 136.39亿 JPY | 2.21亿 JPY |
公司数据更新于 2026年10月7日。
近期已公布业绩
近期已公布业绩
年度分割调整后的每股现金分配。
JP¥40.00
2025年(完整年度)+100.0% 自从 2021
2026年(部分年度):JP¥30.00
JP¥20.00
2,021
JP¥25.00
2,022
JP¥27.50
2,023
JP¥30.00
2,024
JP¥40.00
2,025
JP¥30.00
2,026*
* 在现有股息历史记录中,该日历年仅包含部分期间。
| 行动 | 除息日 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股息即将实施 | 2026年12月29日 | JP¥30.00Semi-Annual | 2026年12月31日 | 2026年12月29日 |
股息 | 2026年6月29日 | JP¥30.00Semi-Annual | 2026年6月30日 | 2026年9月15日 |
股息 | 2025年12月29日 | JP¥22.00Semi-Annual | 2025年12月31日 | 2026年3月12日 |
股息 | 2025年6月27日 | JP¥18.00Semi-Annual | 2025年6月30日 | 2025年9月12日 |
股息 | 2024年12月27日 | JP¥15.00Semi-Annual | 2024年12月31日 | 2025年3月12日 |
股息 | 2024年6月27日 | JP¥15.00Semi-Annual | 2024年6月30日 | 2024年9月12日 |
除息 2026年12月29日
JP¥30.00
Semi-Annual
2026年12月31日登记 · 支付日 2026年12月29日
除息 2026年6月29日
JP¥30.00
Semi-Annual
2026年6月30日登记 · 支付日 2026年9月15日
除息 2025年12月29日
JP¥22.00
Semi-Annual
2025年12月31日登记 · 支付日 2026年3月12日
除息 2025年6月27日
JP¥18.00
Semi-Annual
2025年6月30日登记 · 支付日 2025年9月12日
除息 2024年12月27日
JP¥15.00
Semi-Annual
2024年12月31日登记 · 支付日 2025年3月12日
除息 2024年6月27日
JP¥15.00
Semi-Annual
2024年6月30日登记 · 支付日 2024年9月12日
报告持有此股票敞口的交易所交易基金。
NEXT FUNDS TOPIX Exchange Traded Fund1306.T50.2亿0.01%35.83万亿 JPY0.05%JP¥440.5+0.02%
iShares Core TOPIX ETF1475.T4.58亿0.02%3.04万亿 JPY0.05%JP¥433.9+0.02%
Avantis International Small Cap Value ETFAVDV1725.35万0.09%201.58亿 USD0.36%US$109.2+0.10%
Vanguard Total International Stock ETFVXUS1723.73万0.00%6657亿 USD0.05%US$85.80-0.06%
Vanguard FTSE Developed Markets ETFVEA1166.84万0.00%3238亿 USD0.03%US$71.11-0.03%
iShares Core MSCI EAFE ETFIEFA747.98万0.00%1908.69亿 USD0.07%US$97.25+0.13%
Dimensional - International Small Cap Value ETFDISV617.56万0.12%50.95亿 USD0.42%US$43.13+0.37%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS450.74万0.03%145亿 USD0.06%US$156.32+0.23%
NEXT FUNDS TOPIX Exchange Traded Fund1306.T
iShares Core TOPIX ETF1475.T
Avantis International Small Cap Value ETFAVDV
Vanguard Total International Stock ETFVXUS
Vanguard FTSE Developed Markets ETFVEA
iShares Core MSCI EAFE ETFIEFA
Dimensional - International Small Cap Value ETFDISV
Vanguard FTSE All-World ex-US Small-Cap ETFVSSAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。